Accumulating evidence points to a role for PAR2 in the pathogenic processes that drive CKD prompting us to explore if PAR2 activation in a primary human tubular epithelial cell culture model induces molecules that promote inflammation and fibrosis. The gene discussed is F2RL1; the disease is chronic kidney disease.